Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria?
Display Omitted
Gespeichert in:
| Autor*in: |
Escoll, Pedro [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) - Abbate, Marco T.A. ELSEVIER, 2023, Philadelphia, Pa |
|---|---|
| Übergeordnetes Werk: |
volume:60 ; year:2019 ; pages:117-123 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.coi.2019.05.009 |
|---|
| Katalog-ID: |
ELV04816836X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV04816836X | ||
| 003 | DE-627 | ||
| 005 | 20230624143105.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191023s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.coi.2019.05.009 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000780.pica |
| 035 | |a (DE-627)ELV04816836X | ||
| 035 | |a (ELSEVIER)S0952-7915(18)30128-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Escoll, Pedro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria? |
| 264 | 1 | |c 2019 | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Display Omitted | ||
| 700 | 1 | |a Buchrieser, Carmen |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Current Science |a Abbate, Marco T.A. ELSEVIER |t Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) |d 2023 |g Philadelphia, Pa |w (DE-627)ELV009957871 |
| 773 | 1 | 8 | |g volume:60 |g year:2019 |g pages:117-123 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.coi.2019.05.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |q VZ |
| 951 | |a AR | ||
| 952 | |d 60 |j 2019 |h 117-123 |g 7 | ||
| author_variant |
p e pe |
|---|---|
| matchkey_str |
escollpedrobuchriesercarmen:2019----:eaoirpormignnaeellreecmcaimgis |
| hierarchy_sort_str |
2019 |
| bklnumber |
44.40 |
| publishDate |
2019 |
| allfields |
10.1016/j.coi.2019.05.009 doi GBV00000000000780.pica (DE-627)ELV04816836X (ELSEVIER)S0952-7915(18)30128-6 DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl Escoll, Pedro verfasserin aut Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria? 2019 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Buchrieser, Carmen oth Enthalten in Current Science Abbate, Marco T.A. ELSEVIER Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) 2023 Philadelphia, Pa (DE-627)ELV009957871 volume:60 year:2019 pages:117-123 extent:7 https://doi.org/10.1016/j.coi.2019.05.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 60 2019 117-123 7 |
| spelling |
10.1016/j.coi.2019.05.009 doi GBV00000000000780.pica (DE-627)ELV04816836X (ELSEVIER)S0952-7915(18)30128-6 DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl Escoll, Pedro verfasserin aut Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria? 2019 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Buchrieser, Carmen oth Enthalten in Current Science Abbate, Marco T.A. ELSEVIER Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) 2023 Philadelphia, Pa (DE-627)ELV009957871 volume:60 year:2019 pages:117-123 extent:7 https://doi.org/10.1016/j.coi.2019.05.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 60 2019 117-123 7 |
| allfields_unstemmed |
10.1016/j.coi.2019.05.009 doi GBV00000000000780.pica (DE-627)ELV04816836X (ELSEVIER)S0952-7915(18)30128-6 DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl Escoll, Pedro verfasserin aut Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria? 2019 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Buchrieser, Carmen oth Enthalten in Current Science Abbate, Marco T.A. ELSEVIER Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) 2023 Philadelphia, Pa (DE-627)ELV009957871 volume:60 year:2019 pages:117-123 extent:7 https://doi.org/10.1016/j.coi.2019.05.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 60 2019 117-123 7 |
| allfieldsGer |
10.1016/j.coi.2019.05.009 doi GBV00000000000780.pica (DE-627)ELV04816836X (ELSEVIER)S0952-7915(18)30128-6 DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl Escoll, Pedro verfasserin aut Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria? 2019 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Buchrieser, Carmen oth Enthalten in Current Science Abbate, Marco T.A. ELSEVIER Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) 2023 Philadelphia, Pa (DE-627)ELV009957871 volume:60 year:2019 pages:117-123 extent:7 https://doi.org/10.1016/j.coi.2019.05.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 60 2019 117-123 7 |
| allfieldsSound |
10.1016/j.coi.2019.05.009 doi GBV00000000000780.pica (DE-627)ELV04816836X (ELSEVIER)S0952-7915(18)30128-6 DE-627 ger DE-627 rakwb eng 610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl Escoll, Pedro verfasserin aut Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria? 2019 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Buchrieser, Carmen oth Enthalten in Current Science Abbate, Marco T.A. ELSEVIER Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) 2023 Philadelphia, Pa (DE-627)ELV009957871 volume:60 year:2019 pages:117-123 extent:7 https://doi.org/10.1016/j.coi.2019.05.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.40 Pharmazie Pharmazeutika VZ AR 60 2019 117-123 7 |
| language |
English |
| source |
Enthalten in Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) Philadelphia, Pa volume:60 year:2019 pages:117-123 extent:7 |
| sourceStr |
Enthalten in Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) Philadelphia, Pa volume:60 year:2019 pages:117-123 extent:7 |
| format_phy_str_mv |
Article |
| bklname |
Pharmazie Pharmazeutika |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) |
| authorswithroles_txt_mv |
Escoll, Pedro @@aut@@ Buchrieser, Carmen @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV009957871 |
| dewey-sort |
3610 |
| id |
ELV04816836X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04816836X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624143105.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.coi.2019.05.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000780.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04816836X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0952-7915(18)30128-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Escoll, Pedro</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buchrieser, Carmen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Current Science</subfield><subfield code="a">Abbate, Marco T.A. ELSEVIER</subfield><subfield code="t">Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND)</subfield><subfield code="d">2023</subfield><subfield code="g">Philadelphia, Pa</subfield><subfield code="w">(DE-627)ELV009957871</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:60</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:117-123</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.coi.2019.05.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">60</subfield><subfield code="j">2019</subfield><subfield code="h">117-123</subfield><subfield code="g">7</subfield></datafield></record></collection>
|
| author |
Escoll, Pedro |
| spellingShingle |
Escoll, Pedro ddc 610 ssgn 15,3 fid PHARM bkl 44.40 Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria? |
| authorStr |
Escoll, Pedro |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV009957871 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria? |
| topic |
ddc 610 ssgn 15,3 fid PHARM bkl 44.40 |
| topic_unstemmed |
ddc 610 ssgn 15,3 fid PHARM bkl 44.40 |
| topic_browse |
ddc 610 ssgn 15,3 fid PHARM bkl 44.40 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
c b cb |
| hierarchy_parent_title |
Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) |
| hierarchy_parent_id |
ELV009957871 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV009957871 |
| title |
Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria? |
| ctrlnum |
(DE-627)ELV04816836X (ELSEVIER)S0952-7915(18)30128-6 |
| title_full |
Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria? |
| author_sort |
Escoll, Pedro |
| journal |
Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) |
| journalStr |
Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND) |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
117 |
| author_browse |
Escoll, Pedro |
| container_volume |
60 |
| physical |
7 |
| class |
610 VZ 15,3 ssgn PHARM DE-84 fid 44.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Escoll, Pedro |
| doi_str_mv |
10.1016/j.coi.2019.05.009 |
| dewey-full |
610 |
| title_sort |
metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria? |
| title_auth |
Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria? |
| abstract |
Display Omitted |
| abstractGer |
Display Omitted |
| abstract_unstemmed |
Display Omitted |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA |
| title_short |
Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria? |
| url |
https://doi.org/10.1016/j.coi.2019.05.009 |
| remote_bool |
true |
| author2 |
Buchrieser, Carmen |
| author2Str |
Buchrieser, Carmen |
| ppnlink |
ELV009957871 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1016/j.coi.2019.05.009 |
| up_date |
2024-07-06T18:07:16.481Z |
| _version_ |
1803854006433349632 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04816836X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624143105.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.coi.2019.05.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000780.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04816836X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0952-7915(18)30128-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">15,3</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Escoll, Pedro</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buchrieser, Carmen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Current Science</subfield><subfield code="a">Abbate, Marco T.A. ELSEVIER</subfield><subfield code="t">Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND)</subfield><subfield code="d">2023</subfield><subfield code="g">Philadelphia, Pa</subfield><subfield code="w">(DE-627)ELV009957871</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:60</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:117-123</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.coi.2019.05.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="j">Pharmazie</subfield><subfield code="j">Pharmazeutika</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">60</subfield><subfield code="j">2019</subfield><subfield code="h">117-123</subfield><subfield code="g">7</subfield></datafield></record></collection>
|
| score |
7.3984203 |